Target intelligence / Profile preview

Systemic metabolic and tissue repair pathways via nutrient provision

Molecular classification
Other
01

Overview

Systemic metabolic and tissue repair pathways via nutrient provision refers to a therapeutic strategy that utilizes specific combinations of endogenous metabolites, primarily amino acids, to simultaneously modulate multiple dysregulated biological pathways (Axcella Health, 2021). This approach, pioneered by companies like Axcella Health, aims to restore metabolic homeostasis and promote tissue repair in complex, multi-factorial diseases such as non-alcoholic steatohepatitis (NASH), hepatic encephalopathy, and muscle wasting (Harrison et al., 2021; Mann et al., 2020). Unlike traditional single-target drugs, this strategy leverages the natural signaling and metabolic roles of nutrients to influence systemic health. By providing precise ratios of amino acids, these therapies can activate anabolic pathways (e.g., mTORC1), inhibit catabolic processes, and improve mitochondrial function (Hamill et al., 2020). This multi-targeted mechanism is designed to address the underlying metabolic dysfunction that drives disease progression and tissue damage. It represents a systems-biology approach to medicine, focusing on the restoration of physiological balance rather than the inhibition of a single enzyme or receptor.

Other names
Endogenous Metabolic Modulators (EMMs)Metabolic Reprogramming via Amino AcidsNutritional TherapySystemic Metabolic Pathways
02

Mechanism of action

Simultaneous modulation of multiple metabolic and signaling pathways (e.g., mTOR, AMPK, insulin signaling) through the provision of specific ratios of amino acids and other endogenous metabolites to restore homeostasis and promote tissue repair.

03

Biological functions

MetabolismTissue repairSignal transductionCell growthMitochondrial functionProtein synthesis
04

Disease associations

Non-alcoholic steatohepatitis (NASH)Hepatic encephalopathySarcopeniaMetabolic syndromeCirrhosisLong COVID fatigue
05

Safety considerations

Gastrointestinal distress (nausea, diarrhea)Metabolic imbalancesPalatability issuesRenal strain (at high doses)
06

Interacting drugs

AXA1125

3 more in the full profile.

07

Biomarkers

Plasma amino acid levelsLiver fat content (MRI-PDFF)Fibrosis markers (Pro-C3)Ammonia levelsPsychomotor Hepatic Encephalopathy Score (PHES)

Beyond the preview

Go deeper on Systemic metabolic and tissue repair pathways via nutrient provision.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systemic metabolic and tissue repair pathways via nutrient provision.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call